Report Overview
Non-prescription drugs refer to drugs that can be purchased for the convenience of the public without a prescription from a physician or other medical professional. The general public can use the drugs on their own discretion according to the drug labels and instructions.
This report provides a deep insight into the global OTC Drug market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global OTC Drug Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the OTC Drug market in any manner.
Global OTC Drug Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Bayer HealthCare
GlaxoSmithKline(GSK)
Johnson&Johnson
Pfizer
Sanofi
AstraZeneca
BioGaia
Bristol Myers Squibb
Bukwang Pharmaceutica
Chr. Hansen
Cipla
CoLucid
Daiichi Sankyo
Friggs
DSM
Eisai
Eli Lilly
Herbalife
Euradite
Market Segmentation (by Type)
Class A OTC Drug
Class B OTC Drug
Market Segmentation (by Application)
Hospital
Clinic
Household
Geographic Segmentation
? North America (USA, Canada, Mexico)
? Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
? Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
? South America (Brazil, Argentina, Columbia, Rest of South America)
? The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
? Industry drivers, restraints, and opportunities covered in the study
? Neutral perspective on the market performance
? Recent industry trends and developments
? Competitive landscape & strategies of key players
? Potential & niche segments and regions exhibiting promising growth covered
? Historical, current, and projected market size, in terms of value
? In-depth analysis of the OTC Drug Market
? Overview of the regional outlook of the OTC Drug Market:
Key Reasons to Buy this Report:
? Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
? This enables you to anticipate market changes to remain ahead of your competitors
? You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
? The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
? Provision of market value (USD Billion) data for each segment and sub-segment
? Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
? Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
? Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
? Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
? The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
? Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
? Provides insight into the market through Value Chain
? Market dynamics scenario, along with growth opportunities of the market in the years to come
? 6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the OTC Drug Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
TABLE OF CONTENTS
Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of OTC Drug
1.2 Key Market Segments
1.2.1 OTC Drug Segment by Type
1.2.2 OTC Drug Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 OTC Drug Market Overview
2.1 Global Market Overview
2.1.1 Global OTC Drug Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global OTC Drug Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 OTC Drug Market Competitive Landscape
3.1 Global OTC Drug Sales by Manufacturers (2019-2024)
3.2 Global OTC Drug Revenue Market Share by Manufacturers (2019-2024)
3.3 OTC Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global OTC Drug Average Price by Manufacturers (2019-2024)
3.5 Manufacturers OTC Drug Sales Sites, Area Served, Product Type
3.6 OTC Drug Market Competitive Situation and Trends
3.6.1 OTC Drug Market Concentration Rate
3.6.2 Global 5 and 10 Largest OTC Drug Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 OTC Drug Industry Chain Analysis
4.1 OTC Drug Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of OTC Drug Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 OTC Drug Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global OTC Drug Sales Market Share by Type (2019-2024)
6.3 Global OTC Drug Market Size Market Share by Type (2019-2024)
6.4 Global OTC Drug Price by Type (2019-2024)
7 OTC Drug Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global OTC Drug Market Sales by Application (2019-2024)
7.3 Global OTC Drug Market Size (M USD) by Application (2019-2024)
7.4 Global OTC Drug Sales Growth Rate by Application (2019-2024)
8 OTC Drug Market Segmentation by Region
8.1 Global OTC Drug Sales by Region
8.1.1 Global OTC Drug Sales by Region
8.1.2 Global OTC Drug Sales Market Share by Region
8.2 North America
8.2.1 North America OTC Drug Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe OTC Drug Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific OTC Drug Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America OTC Drug Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa OTC Drug Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Bayer HealthCare
9.1.1 Bayer HealthCare OTC Drug Basic Information
9.1.2 Bayer HealthCare OTC Drug Product Overview
9.1.3 Bayer HealthCare OTC Drug Product Market Performance
9.1.4 Bayer HealthCare Business Overview
9.1.5 Bayer HealthCare OTC Drug SWOT Analysis
9.1.6 Bayer HealthCare Recent Developments
9.2 GlaxoSmithKline(GSK)
9.2.1 GlaxoSmithKline(GSK) OTC Drug Basic Information
9.2.2 GlaxoSmithKline(GSK) OTC Drug Product Overview
9.2.3 GlaxoSmithKline(GSK) OTC Drug Product Market Performance
9.2.4 GlaxoSmithKline(GSK) Business Overview
9.2.5 GlaxoSmithKline(GSK) OTC Drug SWOT Analysis
9.2.6 GlaxoSmithKline(GSK) Recent Developments
9.3 JohnsonandJohnson
9.3.1 JohnsonandJohnson OTC Drug Basic Information
9.3.2 JohnsonandJohnson OTC Drug Product Overview
9.3.3 JohnsonandJohnson OTC Drug Product Market Performance
9.3.4 JohnsonandJohnson OTC Drug SWOT Analysis
9.3.5 JohnsonandJohnson Business Overview
9.3.6 JohnsonandJohnson Recent Developments
9.4 Pfizer
9.4.1 Pfizer OTC Drug Basic Information
9.4.2 Pfizer OTC Drug Product Overview
9.4.3 Pfizer OTC Drug Product Market Performance
9.4.4 Pfizer Business Overview
9.4.5 Pfizer Recent Developments
9.5 Sanofi
9.5.1 Sanofi OTC Drug Basic Information
9.5.2 Sanofi OTC Drug Product Overview
9.5.3 Sanofi OTC Drug Product Market Performance
9.5.4 Sanofi Business Overview
9.5.5 Sanofi Recent Developments
9.6 AstraZeneca
9.6.1 AstraZeneca OTC Drug Basic Information
9.6.2 AstraZeneca OTC Drug Product Overview
9.6.3 AstraZeneca OTC Drug Product Market Performance
9.6.4 AstraZeneca Business Overview
9.6.5 AstraZeneca Recent Developments
9.7 BioGaia
9.7.1 BioGaia OTC Drug Basic Information
9.7.2 BioGaia OTC Drug Product Overview
9.7.3 BioGaia OTC Drug Product Market Performance
9.7.4 BioGaia Business Overview
9.7.5 BioGaia Recent Developments
9.8 Bristol Myers Squibb
9.8.1 Bristol Myers Squibb OTC Drug Basic Information
9.8.2 Bristol Myers Squibb OTC Drug Product Overview
9.8.3 Bristol Myers Squibb OTC Drug Product Market Performance
9.8.4 Bristol Myers Squibb Business Overview
9.8.5 Bristol Myers Squibb Recent Developments
9.9 Bukwang Pharmaceutica
9.9.1 Bukwang Pharmaceutica OTC Drug Basic Information
9.9.2 Bukwang Pharmaceutica OTC Drug Product Overview
9.9.3 Bukwang Pharmaceutica OTC Drug Product Market Performance
9.9.4 Bukwang Pharmaceutica Business Overview
9.9.5 Bukwang Pharmaceutica Recent Developments
9.10 Chr. Hansen
9.10.1 Chr. Hansen OTC Drug Basic Information
9.10.2 Chr. Hansen OTC Drug Product Overview
9.10.3 Chr. Hansen OTC Drug Product Market Performance
9.10.4 Chr. Hansen Business Overview
9.10.5 Chr. Hansen Recent Developments
9.11 Cipla
9.11.1 Cipla OTC Drug Basic Information
9.11.2 Cipla OTC Drug Product Overview
9.11.3 Cipla OTC Drug Product Market Performance
9.11.4 Cipla Business Overview
9.11.5 Cipla Recent Developments
9.12 CoLucid
9.12.1 CoLucid OTC Drug Basic Information
9.12.2 CoLucid OTC Drug Product Overview
9.12.3 CoLucid OTC Drug Product Market Performance
9.12.4 CoLucid Business Overview
9.12.5 CoLucid Recent Developments
9.13 Daiichi Sankyo
9.13.1 Daiichi Sankyo OTC Drug Basic Information
9.13.2 Daiichi Sankyo OTC Drug Product Overview
9.13.3 Daiichi Sankyo OTC Drug Product Market Performance
9.13.4 Daiichi Sankyo Business Overview
9.13.5 Daiichi Sankyo Recent Developments
9.14 Friggs
9.14.1 Friggs OTC Drug Basic Information
9.14.2 Friggs OTC Drug Product Overview
9.14.3 Friggs OTC Drug Product Market Performance
9.14.4 Friggs Business Overview
9.14.5 Friggs Recent Developments
9.15 DSM
9.15.1 DSM OTC Drug Basic Information
9.15.2 DSM OTC Drug Product Overview
9.15.3 DSM OTC Drug Product Market Performance
9.15.4 DSM Business Overview
9.15.5 DSM Recent Developments
9.16 Eisai
9.16.1 Eisai OTC Drug Basic Information
9.16.2 Eisai OTC Drug Product Overview
9.16.3 Eisai OTC Drug Product Market Performance
9.16.4 Eisai Business Overview
9.16.5 Eisai Recent Developments
9.17 Eli Lilly
9.17.1 Eli Lilly OTC Drug Basic Information
9.17.2 Eli Lilly OTC Drug Product Overview
9.17.3 Eli Lilly OTC Drug Product Market Performance
9.17.4 Eli Lilly Business Overview
9.17.5 Eli Lilly Recent Developments
9.18 Herbalife
9.18.1 Herbalife OTC Drug Basic Information
9.18.2 Herbalife OTC Drug Product Overview
9.18.3 Herbalife OTC Drug Product Market Performance
9.18.4 Herbalife Business Overview
9.18.5 Herbalife Recent Developments
9.19 Euradite
9.19.1 Euradite OTC Drug Basic Information
9.19.2 Euradite OTC Drug Product Overview
9.19.3 Euradite OTC Drug Product Market Performance
9.19.4 Euradite Business Overview
9.19.5 Euradite Recent Developments
10 OTC Drug Market Forecast by Region
10.1 Global OTC Drug Market Size Forecast
10.2 Global OTC Drug Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe OTC Drug Market Size Forecast by Country
10.2.3 Asia Pacific OTC Drug Market Size Forecast by Region
10.2.4 South America OTC Drug Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of OTC Drug by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global OTC Drug Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of OTC Drug by Type (2025-2030)
11.1.2 Global OTC Drug Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of OTC Drug by Type (2025-2030)
11.2 Global OTC Drug Market Forecast by Application (2025-2030)
11.2.1 Global OTC Drug Sales (Kilotons) Forecast by Application
11.2.2 Global OTC Drug Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings
LIST OF TABLES & FIGURES
List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. OTC Drug Market Size Comparison by Region (M USD)
Table 5. Global OTC Drug Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global OTC Drug Sales Market Share by Manufacturers (2019-2024)
Table 7. Global OTC Drug Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global OTC Drug Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in OTC Drug as of 2022)
Table 10. Global Market OTC Drug Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers OTC Drug Sales Sites and Area Served
Table 12. Manufacturers OTC Drug Product Type
Table 13. Global OTC Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of OTC Drug
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. OTC Drug Market Challenges
Table 22. Global OTC Drug Sales by Type (Kilotons)
Table 23. Global OTC Drug Market Size by Type (M USD)
Table 24. Global OTC Drug Sales (Kilotons) by Type (2019-2024)
Table 25. Global OTC Drug Sales Market Share by Type (2019-2024)
Table 26. Global OTC Drug Market Size (M USD) by Type (2019-2024)
Table 27. Global OTC Drug Market Size Share by Type (2019-2024)
Table 28. Global OTC Drug Price (USD/Ton) by Type (2019-2024)
Table 29. Global OTC Drug Sales (Kilotons) by Application
Table 30. Global OTC Drug Market Size by Application
Table 31. Global OTC Drug Sales by Application (2019-2024) & (Kilotons)
Table 32. Global OTC Drug Sales Market Share by Application (2019-2024)
Table 33. Global OTC Drug Sales by Application (2019-2024) & (M USD)
Table 34. Global OTC Drug Market Share by Application (2019-2024)
Table 35. Global OTC Drug Sales Growth Rate by Application (2019-2024)
Table 36. Global OTC Drug Sales by Region (2019-2024) & (Kilotons)
Table 37. Global OTC Drug Sales Market Share by Region (2019-2024)
Table 38. North America OTC Drug Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe OTC Drug Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific OTC Drug Sales by Region (2019-2024) & (Kilotons)
Table 41. South America OTC Drug Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa OTC Drug Sales by Region (2019-2024) & (Kilotons)
Table 43. Bayer HealthCare OTC Drug Basic Information
Table 44. Bayer HealthCare OTC Drug Product Overview
Table 45. Bayer HealthCare OTC Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. Bayer HealthCare Business Overview
Table 47. Bayer HealthCare OTC Drug SWOT Analysis
Table 48. Bayer HealthCare Recent Developments
Table 49. GlaxoSmithKline(GSK) OTC Drug Basic Information
Table 50. GlaxoSmithKline(GSK) OTC Drug Product Overview
Table 51. GlaxoSmithKline(GSK) OTC Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. GlaxoSmithKline(GSK) Business Overview
Table 53. GlaxoSmithKline(GSK) OTC Drug SWOT Analysis
Table 54. GlaxoSmithKline(GSK) Recent Developments
Table 55. JohnsonandJohnson OTC Drug Basic Information
Table 56. JohnsonandJohnson OTC Drug Product Overview
Table 57. JohnsonandJohnson OTC Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. JohnsonandJohnson OTC Drug SWOT Analysis
Table 59. JohnsonandJohnson Business Overview
Table 60. JohnsonandJohnson Recent Developments
Table 61. Pfizer OTC Drug Basic Information
Table 62. Pfizer OTC Drug Product Overview
Table 63. Pfizer OTC Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. Pfizer Business Overview
Table 65. Pfizer Recent Developments
Table 66. Sanofi OTC Drug Basic Information
Table 67. Sanofi OTC Drug Product Overview
Table 68. Sanofi OTC Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 69. Sanofi Business Overview
Table 70. Sanofi Recent Developments
Table 71. AstraZeneca OTC Drug Basic Information
Table 72. AstraZeneca OTC Drug Product Overview
Table 73. AstraZeneca OTC Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 74. AstraZeneca Business Overview
Table 75. AstraZeneca Recent Developments
Table 76. BioGaia OTC Drug Basic Information
Table 77. BioGaia OTC Drug Product Overview
Table 78. BioGaia OTC Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 79. BioGaia Business Overview
Table 80. BioGaia Recent Developments
Table 81. Bristol Myers Squibb OTC Drug Basic Information
Table 82. Bristol Myers Squibb OTC Drug Product Overview
Table 83. Bristol Myers Squibb OTC Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 84. Bristol Myers Squibb Business Overview
Table 85. Bristol Myers Squibb Recent Developments
Table 86. Bukwang Pharmaceutica OTC Drug Basic Information
Table 87. Bukwang Pharmaceutica OTC Drug Product Overview
Table 88. Bukwang Pharmaceutica OTC Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 89. Bukwang Pharmaceutica Business Overview
Table 90. Bukwang Pharmaceutica Recent Developments
Table 91. Chr. Hansen OTC Drug Basic Information
Table 92. Chr. Hansen OTC Drug Product Overview
Table 93. Chr. Hansen OTC Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 94. Chr. Hansen Business Overview
Table 95. Chr. Hansen Recent Developments
Table 96. Cipla OTC Drug Basic Information
Table 97. Cipla OTC Drug Product Overview
Table 98. Cipla OTC Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 99. Cipla Business Overview
Table 100. Cipla Recent Developments
Table 101. CoLucid OTC Drug Basic Information
Table 102. CoLucid OTC Drug Product Overview
Table 103. CoLucid OTC Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 104. CoLucid Business Overview
Table 105. CoLucid Recent Developments
Table 106. Daiichi Sankyo OTC Drug Basic Information
Table 107. Daiichi Sankyo OTC Drug Product Overview
Table 108. Daiichi Sankyo OTC Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 109. Daiichi Sankyo Business Overview
Table 110. Daiichi Sankyo Recent Developments
Table 111. Friggs OTC Drug Basic Information
Table 112. Friggs OTC Drug Product Overview
Table 113. Friggs OTC Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 114. Friggs Business Overview
Table 115. Friggs Recent Developments
Table 116. DSM OTC Drug Basic Information
Table 117. DSM OTC Drug Product Overview
Table 118. DSM OTC Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 119. DSM Business Overview
Table 120. DSM Recent Developments
Table 121. Eisai OTC Drug Basic Information
Table 122. Eisai OTC Drug Product Overview
Table 123. Eisai OTC Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 124. Eisai Business Overview
Table 125. Eisai Recent Developments
Table 126. Eli Lilly OTC Drug Basic Information
Table 127. Eli Lilly OTC Drug Product Overview
Table 128. Eli Lilly OTC Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 129. Eli Lilly Business Overview
Table 130. Eli Lilly Recent Developments
Table 131. Herbalife OTC Drug Basic Information
Table 132. Herbalife OTC Drug Product Overview
Table 133. Herbalife OTC Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 134. Herbalife Business Overview
Table 135. Herbalife Recent Developments
Table 136. Euradite OTC Drug Basic Information
Table 137. Euradite OTC Drug Product Overview
Table 138. Euradite OTC Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 139. Euradite Business Overview
Table 140. Euradite Recent Developments
Table 141. Global OTC Drug Sales Forecast by Region (2025-2030) & (Kilotons)
Table 142. Global OTC Drug Market Size Forecast by Region (2025-2030) & (M USD)
Table 143. North America OTC Drug Sales Forecast by Country (2025-2030) & (Kilotons)
Table 144. North America OTC Drug Market Size Forecast by Country (2025-2030) & (M USD)
Table 145. Europe OTC Drug Sales Forecast by Country (2025-2030) & (Kilotons)
Table 146. Europe OTC Drug Market Size Forecast by Country (2025-2030) & (M USD)
Table 147. Asia Pacific OTC Drug Sales Forecast by Region (2025-2030) & (Kilotons)
Table 148. Asia Pacific OTC Drug Market Size Forecast by Region (2025-2030) & (M USD)
Table 149. South America OTC Drug Sales Forecast by Country (2025-2030) & (Kilotons)
Table 150. South America OTC Drug Market Size Forecast by Country (2025-2030) & (M USD)
Table 151. Middle East and Africa OTC Drug Consumption Forecast by Country (2025-2030) & (Units)
Table 152. Middle East and Africa OTC Drug Market Size Forecast by Country (2025-2030) & (M USD)
Table 153. Global OTC Drug Sales Forecast by Type (2025-2030) & (Kilotons)
Table 154. Global OTC Drug Market Size Forecast by Type (2025-2030) & (M USD)
Table 155. Global OTC Drug Price Forecast by Type (2025-2030) & (USD/Ton)
Table 156. Global OTC Drug Sales (Kilotons) Forecast by Application (2025-2030)
Table 157. Global OTC Drug Market Size Forecast by Application (2025-2030) & (M USD)
List of Figures
Figure 1. Product Picture of OTC Drug
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global OTC Drug Market Size (M USD), 2019-2030
Figure 5. Global OTC Drug Market Size (M USD) (2019-2030)
Figure 6. Global OTC Drug Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. OTC Drug Market Size by Country (M USD)
Figure 11. OTC Drug Sales Share by Manufacturers in 2023
Figure 12. Global OTC Drug Revenue Share by Manufacturers in 2023
Figure 13. OTC Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market OTC Drug Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by OTC Drug Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global OTC Drug Market Share by Type
Figure 18. Sales Market Share of OTC Drug by Type (2019-2024)
Figure 19. Sales Market Share of OTC Drug by Type in 2023
Figure 20. Market Size Share of OTC Drug by Type (2019-2024)
Figure 21. Market Size Market Share of OTC Drug by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global OTC Drug Market Share by Application
Figure 24. Global OTC Drug Sales Market Share by Application (2019-2024)
Figure 25. Global OTC Drug Sales Market Share by Application in 2023
Figure 26. Global OTC Drug Market Share by Application (2019-2024)
Figure 27. Global OTC Drug Market Share by Application in 2023
Figure 28. Global OTC Drug Sales Growth Rate by Application (2019-2024)
Figure 29. Global OTC Drug Sales Market Share by Region (2019-2024)
Figure 30. North America OTC Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America OTC Drug Sales Market Share by Country in 2023
Figure 32. U.S. OTC Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada OTC Drug Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico OTC Drug Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe OTC Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe OTC Drug Sales Market Share by Country in 2023
Figure 37. Germany OTC Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France OTC Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. OTC Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy OTC Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia OTC Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific OTC Drug Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific OTC Drug Sales Market Share by Region in 2023
Figure 44. China OTC Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan OTC Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea OTC Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India OTC Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia OTC Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America OTC Drug Sales and Growth Rate (Kilotons)
Figure 50. South America OTC Drug Sales Market Share by Country in 2023
Figure 51. Brazil OTC Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina OTC Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia OTC Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa OTC Drug Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa OTC Drug Sales Market Share by Region in 2023
Figure 56. Saudi Arabia OTC Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE OTC Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt OTC Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria OTC Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa OTC Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global OTC Drug Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global OTC Drug Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global OTC Drug Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global OTC Drug Market Share Forecast by Type (2025-2030)
Figure 65. Global OTC Drug Sales Forecast by Application (2025-2030)
Figure 66. Global OTC Drug Market Share Forecast by Application (2025-2030)
